AGC Biologics Expands Pharmaceutical Contract
AGC Biologics expanded a pharmaceutical contract.
Related stories
Zhongke Feice Chairman Proposes Share Buyback
Zhongke Feice said its controlling shareholder, chairman and general manager proposed repurchasing company shares for 1–1.5亿元.
L impact | EQUITY | Nov 03, 2026, 09:44 AM UTC
Rane (Madras) Reports Q2 Consolidated Revenue of INR 12,371.4 Million
M impact | EQUITY | Nov 03, 2026, 09:43 AM UTC
Rane (Madras) Reports Q2 Consolidated Net Profit of INR 3,266.8 Million
M impact | EQUITY | Nov 03, 2026, 09:43 AM UTC
SalMar Q3 Profit Jumps and Raises FY2026 Harvest Outlook
SalMar reported higher third-quarter profit year over year, supported by harvest volume growth, and raised its full-year 2026 harvest volume outlook.
M impact | EQUITY | Nov 03, 2026, 09:42 AM UTC
Freja eID Group to Host Investor Webinar on Q3 Results
Freja eID Group will host an investor webinar on its Q3 results.
M impact | EQUITY | Nov 03, 2026, 09:42 AM UTC
VRL Logistics Shares Jump 14% to a 52-Week High on Q2 Profit Growth
VRL Logistics shares rose over 14% to a fresh 52-week high after the company reported more than a two-fold year-on-year increase in second-quarter profit, alongside strong revenue
M impact | EQUITY | Nov 03, 2026, 09:41 AM UTC